CDC puts $25 million in healthcare finance firm:
This article was originally published in Clinica
London, UK-based CDC Capital Partners has invested $25 million in DVI, a speciality finance company for healthcare providers worldwide. Over 80% of DVI's business is in the US, but the company under CEO Michael O'Hanlon is expanding its presence elsewhere, especially in Latin America, South Africa and Asia. Its main business is to provide lease finance to privately-owned outpatient clinics to enable them to buy diagnostic imaging and medical equipment.
You may also be interested in...
Stephen Hahn’s low visibility period as the newly installed FDA commissioner comes to an abrupt end. Trump offers generous praise amid COVID-19 response – but how quickly might that change to blame?
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.